A Canadian man appears to be free of HIV after a stem cell transplant using cells from an HIV-resistant donor, potentially making him the eleventh person to be cured after the procedure, researchers reported this week at the Canadian...
aidsmap started with a simple but powerful idea – that the latest information about HIV should be easily available for healthcare providers and able to be shared with someone with HIV and their friends and family. For decades, that...
In the early 1990s, a secret HIV vaccine research project was carried out in the Central African Republic. The project didn't yield results and was hidden for many years. Today it sheds light on debates over clinical trials, access to...
As HIV prevention tools improve, the way people perceive their risk of HIV is quietly shifting. Many people now feel more protected than ever before, but does that confidence come with unintended consequences? Imagine wearing a seatbelt...
What if HIV prevention didn’t require daily reminders or constant planning? The rise of long-acting options has sparked a shift, and the lifestyle impact of lenacapavir goes far beyond medical convenience. While science often takes...
Early-onset Kaposi sarcoma in HIV-negative men is a distinct disease subgroup and is usually managed with local therapy rather than systemic treatment. Medscape Medical News
When we hear about breakthroughs in HIV treatment or prevention, it’s easy to assume everyone benefits equally. However, that’s rarely the case. HIV health disparities continue to shape who gains access to these advancements and who gets...
Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University, have developed a new vaccine strategy that has generated antibodies capable of neutralizing highly divergent...
When a promising HIV drug makes headlines, it can feel like help is just around the corner. However, the HIV treatment approval process is far more complex than most people realize. Before any new therapy reaches your doctor’s office, it...
Fewer patients are visiting some HIV treatment centres in Senegal amid a wave of arrests targeting LGBTQ people, threatening the country's fight against the virus. Reuters Health Information
Every year, major HIV conferences generate bold headlines that promise breakthroughs and hope. However, when HIV research news is clearly explained, it often tells a more careful story. While announcements can sound revolutionary, many...
Efforts to prevent HIV have come a long way in recent years, especially with the rise of effective medications like PrEP and antiretroviral therapy. However, is medication alone enough to stop the spread of HIV? Not quite. While these...
Ghana has rejected a bilateral health deal with the U.S., a source familiar with the negotiations told Reuters, the latest stumbling block to the Trump administration's... Reuters Health Information
A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who need a stem cell transplant.
Barriers to HIV prevention continue to limit the reach of life-saving tools, even though modern options are highly effective. So why do many people still miss out? Imagine having a powerful shield but not knowing where to find it or...
Have you ever noticed how stress or illness can make it harder to think clearly? For people living with HIV, this experience can sometimes extend beyond temporary lapses. Today, the impact of HIV on brain health is gaining more attention...
The introduction of HAART for HIV has coincided with a syphilis resurgence, suggesting unintended public health trade-offs from this medical breakthrough.
Patients with HIV infection who receive a liver transplant may face a similar risk of developing new cancers as those without HIV infection. Medscape News UK
Doxycycline post-exposure prophylaxis in Seattle is linked to a halving of syphilis diagnoses overall and a reduction of cases by a third in transgender people. Despite very low uptake, women also experienced a significant drop in...
People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked. FIU researchers have now uncovered a previously unknown mechanism that helps explain how HIV causes emphysema...
Physicians reveal how well their incomes help build family net worth, as well as investment and spending philosophies. Wealth disparities are reported by gender and race. Medscape
The incidence of gonorrhea continues to rise across Europe, while recent vaccine trials show limited efficacy, raising concerns about prevention strategies. Medscape News Global
What would it feel like to pause a treatment that keeps you healthy every day? For many people living with HIV, this becomes a real question during a clinical trial experience for people living with HIV. Some studies ask participants to...
When it comes to HIV medication, many patients think they'd prefer an occasional injection over a daily pill, but uptake remains an issue, according to a Rutgers Health-led survey. When researchers surveyed 801 people living with HIV in...
In a landmark achievement for Caribbean public health, the World Health Organization (WHO) congratulates The Bahamas for becoming the latest Caribbean nation to be certified as having eliminated the mother-to-child transmission of HIV.
Can HIV really stay controlled without medication, or is that still a distant goal? This question is at the heart of ongoing research into HIV remission, a growing field that looks beyond daily treatment and toward long-term control of...
A study in Health Economics uncovered an unintended consequence of a major medical breakthrough: while the availability of HIV treatments in the late 1990s dramatically improved survival, they also contributed to a resurgence in...
Some people living with HIV develop antibodies capable of neutralizing many different strains of the virus. New research links this to immune responses that occur early in infection. The findings, published in PLOS Pathogens, come from...
The human immunodeficiency virus (HIV), which is the cause of AIDS, is a master of deception, using just nine genes to hijack the complex cellular machinery of the human body.
New data released Friday show that the President's Emergency Plan for AIDS Relief (PEPFAR) treated about the same number of people in the last quarter of 2025 as it did a year earlier in 2024.
The human immunodeficiency virus (HIV), which is the cause of AIDS, is a master of deception, using just nine genes to hijack the complex cellular machinery of the human body. Yet, even after decades of research on how the virus...
A major study presented at ESCMID Global 2026 has found that antiretroviral therapy (ART) reduces accelerated biological aging in people with HIV (PWH) by nearly four years, a finding that could transform how clinicians monitor HIV...
aidsmap has long been one of the world's leading sources of accurate, independent HIV information. After a period of uncertainty, aidsmap is back – and one of our priorities is reviving Emerging Voices, a programme to train and support a...
A qualitative study of adolescents living with HIV in Malawi has found that outdated beliefs about HIV, and stereotypes of people with it, contribute to pervasive and persistent stigma against young people living with the virus. This...
Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat. Even with effective antiretroviral therapy, immune cells infected with HIV can hide and lie inactive in certain areas of the body called...
An increasing number of U.S. states have passed laws that allow health care providers—including doctors, nurses, and pharmacists—to refuse to treat patients based on their personal or religious beliefs. While these conscientious...
The composition of gut bacteria appears to be associated with how much latent HIV remains in the blood of people receiving antiretroviral therapy. This is shown in a new study from Karolinska Institutet, published in Gut Pathogens. The...
The withdrawal of US funding for global HIV programmes was a defining theme at the Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver in February. Researchers and advocates grappled with both the immediate...
From a contested study on U=U to a disappointing gonorrhoea vaccine trial and the ongoing global PrEP crisis, HIV prevention was a key topic at this year's Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver....
Timely HIV diagnosis and treatment are critical to preventing transmission. To help make this happen, the U.S. Centers for Disease Control and Prevention (CDC) provides funding for HIV testing to local health departments and community...
A new sexual health survey reveals a mix of progress and persistent gaps. Overall, many Americans report positive experiences—interest in having sex, sexual pleasure, and good communication with partners—yet women and gender-diverse...
The search for a way to control HIV without antiretroviral therapy (ART) continued to generate both promising signals and sobering setbacks at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver. Here...
Africa is home to the majority of people living with HIV and the region hardest hit by the donor funding crisis. At this year's Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver, there was promising science...
As more people live longer with HIV, managing other health conditions is increasingly important. Research presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver covered a wide range of...
The HIV treatment landscape is changing fast. Research presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver pointed towards a future of fewer pills, less frequent dosing and new drug...
Diabetes mellitus affects more than 10% of people with HIV, and its incidence is rising as the population ages, according to the National Institutes of Health. Antiretroviral therapies that treat HIV by blocking specific enzymes the...
Beyond both being viruses, HIV-1 and SARS-CoV-2 don't seem to have a lot in common. HIV-1 is a retrovirus that integrates with its host's DNA for life and can be passed down from mother to child, while SARS-CoV-2 is contagious but...
Several presentations at last month’s Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver, US provided hope for the development of therapeutic vaccinations as well as T-cell and antibody therapies that could...